Advertisement

Topics

Capital Royalty L.P. Company Profile

20:27 EDT 22nd September 2017 | BioPortfolio

Our diversified team of investment professionals is dedicated to meeting the specific needs of each client, and with our extensive experience in the healthcare and financial industries, Capital Royalty has the market knowledge and financial know how necessary to help you maximize the value of your royalty interest.

Location

1000 Main, Suite 2500
Houston
Texas
77002
United States of America

Contact

Phone: (713) 209-7350
Fax: (713) 209-7351
Email: jwebster@capitalroyalty.com


News Articles [561 Associated News Articles listed on BioPortfolio]

DRI Capital Celebrates 20 Years of Healthcare Royalty Investing

TORONTO, Jan. 6, 2013 /PRNewswire/ -- DRI Capital ("DRI"), a pioneer in the global field of pharmaceutical royalty monetization, is pleased to announce the completion of over $600 million in tran...

HealthCare Royalty Partners Promotes Matthew Reber to Managing Director

STAMFORD, Conn., June 27, 2013 /PRNewswire/ -- HealthCare Royalty Partners ("HC Royalty"), a global healthcare investment firm, today announced that Matthew Q. Reber has been promoted to Managing Dire...

Adamas Signs $100 Million Royalty-Backed Note Agreement with HealthCare Royalty Partners

EMERYVILLE, Calif., May 11, 2017 (GLOBE NEWSWIRE) -- Adamas Pharmaceuticals, Inc. (Nasdaq:ADMS) today announced that it has entered into a $100 million royalty-backed note agreement with HealthCa...

HealthCare Royalty Partners Commits Over $300 Million in New Investments in December and Over $425 Million in 2012

STAMFORD, Conn., Jan. 3, 2013 /PRNewswire/ -- HealthCare Royalty Partners ("HC Royalty"), a global healthcare investment firm, today announced that it committed over $300 million in December...

PDL BioPharma Updates Presentation Time for Cantor Fitzgerald Conference

INCLINE VILLAGE, Nev., Sept. 19, 2017 /PRNewswire/ -- PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI) today announced that John P. McLaughlin, PDL's chief executive officer, will present at the 2017 Can...

Dr. Robert S. Langer Joins HealthCare Royalty Partners Strategic Advisory Board

STAMFORD, Conn., Jan. 4, 2013 /PRNewswire/ -- HealthCare Royalty Partners ("HC Royalty"), a global healthcare investment firm, today announced that Dr. Robert S. Langer, Institute Professor ...

Adamas gets $100M via royalty deal with HealthCare

HealthCare Royalty Partners will pay Adamas Pharmaceuticals $35 million now followed by an additional $65 million upon FDA ap -More- 

PDL BioPharma (PDLI) - Depomed paying off

Edison Investment Research - Pharmaceutical & healthcare - PDL BioPharma: PDL BioPharma recently reported strong Q217 earnings mainly due to royalties related to the authorized generic of Glumetza as ...

PubMed Articles [124 Associated PubMed Articles listed on BioPortfolio]

A Tale of Two Towns: A Comparative Study Exploring the Possibilities and Pitfalls of Social Capital among People Seeking Recovery from Substance Misuse.

Social capital has become an influential concept in debating and understanding the modern world. Within the drug and alcohol sector, the concept of 'recovery capital' has gained traction with research...

Examination of the influence of social capital on depression in fragile families.

While it appears that social capital has a positive effect on mental health, most studies have been cross-sectional in nature and/or employ weak measures of social capital or mental health. Even less ...

Twenty years of social capital and health research: a glossary.

Research on social capital in public health is approaching its 20th anniversary. Over this period, there have been rich and productive debates on the definition, measurement and importance of social c...

Perceptions of community, social capital, and how they affect self-reported health: a multilevel analysis.

The link between social capital and self-reported health has been widely explored. On the other hand, we know less about the relationship between social capital, community socioeconomic characteristic...

The effect of migration on social capital and depression among older adults in China.

An estimated 9 million elderly people accompanied their adult children to urban areas in China, raising concerns about their social capital and mental health following re-location. The aim of this stu...

Clinical Trials [31 Associated Clinical Trials listed on BioPortfolio]

Slipped Capital Femoral Epiphysis Treatment

Slipped capital femoral epiphysis represents approximately 10.8 cases per 100,000 children. The primary source for the blood supply of the head of the femur is the deep branch of the media...

Social Inequalities in Emergency Call and Emergency Response Patterns

Background: Inequality in access to healthcare is a challenge internationally. Despite that medical emergency calls can be considered as access point to pre-hospital emergency care and ...

To Develop a Validated Program and Use it to Evaluate Patients Post-operatively

Annually, the Department of Anesthesiology, Siriraj hospital has responsibilities to take care of more than 50,000 patients peri-operatively. According to Maslow's hierarchy of needs; huma...

Treatment of Sub-Capital Fractures of Hip Joint by Using TriboFit™ Acetabular Buffer

The purpose of this study is to determine the performance and efficacy during 6 and 12 month post operation. 1. determine changes in patient pain level 2. determine changes in ...

Evaluation of Four Reconstructions After Total Gastrectomy

There are four capital reconstructions after total gastrectomy which is widely used in China. Life quality is the only standard to evaluate postoperative results of different reconstructio...

Companies [1032 Associated Companies listed on BioPortfolio]

Capital Royalty L.P.

Our diversified team of investment professionals is dedicated to meeting the specific needs of each client, and with our extensive experience in the healthcare and financial industries, Capital Royalt...

DRUG ROYALTY CORPORATION INC

A pioneer in the field when launched in 1992, Drug Royalty was the first firm to provide royalty-based financing in the life sciences sector and the first to complete royalty transactions with invento...

DRI Capital Inc.

DRI is a pioneer and global leader in healthcare royalty investing and has completed transactions with large global pharmaceutical companies, biotechnology companies, universities...

Drug Royalty

Drug Royalty is an innovative and profitable Canadian company involved in the international life science industry. Established in 1992, DRC was designed to participate in the growth from the global he...

HealthCare Royalty Partners

HealthCare Royalty Partners (HCRP) is a global healthcare investment firm focused on investing primarily in commercial stage healthcare product assets. HCRP manages over $3 billio...

More Information about "Capital Royalty L.P." on BioPortfolio

We have published hundreds of Capital Royalty L.P. news stories on BioPortfolio along with dozens of Capital Royalty L.P. Clinical Trials and PubMed Articles about Capital Royalty L.P. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Capital Royalty L.P. Companies in our database. You can also find out about relevant Capital Royalty L.P. Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topic

Healthcare
Health care (or healthcare) is the diagnosis, treatment, and prevention of disease, illness, injury, and other physical and mental impairments in humans. Health care is delivered by practitioners in medicine, chiropractic, dentistry, nursing, pharmacy, a...


Corporate Database Quicklinks



Searches Linking to this Company Record